Login
$IRD
$4.10 +$0.06 (1.49%) After hours

Ownership

13F as of Q2 2026 · 101.8M shares outstanding

Who owns IRD?

By type of holder
Institutions 96.2% Insiders 3.8% Everyone else 0.0%
Concentration Top 10 holders own 53.0%
BIOS Capital Management, LP 6.6% · Vanguard Capital Management LLC 6.2%
Institutional ownership
96.2%
+40.5 pts vs last qtr
Institutional holders
137
+31 vs last qtr
Net shares bought
+41.2M
by institutions in Q2 2026
New / sold out
51 / 20
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Cable Car Capital, LP +4.8M
  • ADAR1 Capital Management, LLC +4.4M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Perceptive Advisors LLC SOLD OUT −1.8M
  • Farallon Capital Management, L.L.C. SOLD OUT −1.0M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$819K
14 notices from 5 people
Shares covered
175.6K
0.17% of the company
Arranged in advance
22%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$135.4K$270.8KDecJanFebMar 2026: $127.3K without a planMarApr 2026: $270.8K without a planAprMayJunJul 2026: $88.4K without a planJulAugSep 2026: $124.6K under a 10b5-1 planSepOct 2026: $56.1K under a 10b5-1 planOct 2026: $151.7K without a planOctNov
Largest proposed sellers
  • Magrath George Officer $318K
  • Gagnon Robert E. Officer $245K

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+3143.0%
+47.19% a year
Each share's claim on the business
−96.9%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $19.5M
over 10 fiscal years
Diluted shares, split-adjusted
1.9M32.4M62.8M2016: 1.9M shares'162017: 2.4M shares'172018: 2.9M shares'182019: 3.0M shares'192020: 4.7M shares'202021: 14.9M shares'212022: 20.6M shares'222023: 21.6M shares'232024: 26.7M shares'242025: 62.2M shares'25
Buybacks Stock-based comp
$0$1.8M$3.5M2016 buybacks: $02016 stock comp: $1.4M'162017 buybacks: $02017 stock comp: $1.0M'172018 buybacks: $02018 stock comp: $1.2M'182019 buybacks: $02019 stock comp: $308.0K'192020 buybacks: $02020 stock comp: $1.5M'202021 buybacks: $02021 stock comp: $1.9M'212022 buybacks: $02022 stock comp: $1.8M'222023 buybacks: $02023 stock comp: $3.5M'232024 buybacks: $02024 stock comp: $3.4M'242025 buybacks: $02025 stock comp: $3.4M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years15% 3–5 years1% 1–3 years32% Under 1 year52%
Quarterly turnover
46.9%
of institutional shares changed hands
Top 10 managers, median time held
1.5 years

Super Investors

Investment managers reporting IRD on Form 13F
BC
BIOS Capital Management, LP
Shares
6.7M
% of company
6.55%
Change vs last qtr
+1.0M (+17.6%)
Held since
2024
VC
Vanguard Capital Management LLC
Shares
6.3M
% of company
6.22%
Change vs last qtr
+2.9M (+83.7%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Opus Genetics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting IRD on Form N-PORT; together they hold 11.2% of the company
VT
Position value
$11.8M
% of company
4.68%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Trust
Position value
$5.54M
% of company
1.32%
% of the fund
0.01%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Opus Genetics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
FF
Foundation Fighting Blindness Retinal Degeneration Fund
5%+ holder13D · 4.7%
Shares
3.8M
% of company
3.72%
Change vs last qtr
—
Held since
—
FF
Foundation Fighting Blindness, Inc.
5%+ holder13D · 4.7%
Shares
3.8M
% of company
3.72%
Change vs last qtr
—
Held since
—

15 more holders behind a free account

See every insider and 5%+ holder of Opus Genetics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support